Benzinga | Nov 8, 2021 07:10AM EST

Axsome Therapeutics Q3 EPS $(0.93) Beats $(0.95) Estimate

Axsome Therapeutics (NASDAQ:AXSM) reported quarterly losses of $(0.93) per share which beat the analyst consensus estimate of $(0.95) by 2.11 percent. This is a 52.46 percent decrease over losses of $(0.61) per share from the same period last year.